Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Radiation Injuries × olaparib × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 37 Ovarian Neoplasms 31 Prostatic Neoplasms 18 Triple Negative Breast Neoplasms 16 Fallopian Tube Neoplasms 16 Neoplasm Metastasis 11 Neoplasms 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 5 Sarcoma 5 Glioma 5 Lung Neoplasms 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2

Interventions

Radiotherapy 8 Heavy Ion Radiotherapy 2 Brachytherapy 2 sodium propionate 1 olaparib 1 Xylitol 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiosurgery 1 Radiography, Panoramic 1 Probiotics 1 Poly A 1 Oxygen 1 Oral Hygiene 1 Menogaril 1 Lymph Node Excision 1 Lisinopril 1 Immunotherapy 1 Hyperbaric Oxygenation 1 Fatty Acids, Volatile 1 Fatty Acids, Omega-3 1 Etoposide 1 Dexamethasone 1 Cisplatin 1 Chemoradiotherapy 1 Carboplatin 1 Butyric Acid 1 Bevacizumab 1 Betaine 1 Base Sequence 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03109080 2025-11-24

RadioPARP

Institut Curie

Phase 1 Completed

Radiation Injuries, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡